Literature DB >> 10025800

Utilization of unconventional treatments by persons with MS: is it alternative or complementary?

C E Schwartz1, E Laitin, S Brotman, N LaRocca.   

Abstract

This cross-sectional mail survey evaluated the prevalence and predictors of unconventional therapy (UT) utilization among 569 community-based people with MS. One-third reported having visited a UT practitioner in the last 6 months. Utilizers tended to report at least one medical comorbidity, earn at least $50,000 a year, and engage in preventive health behaviors; they also used more outpatient services and reported higher levels of interpersonal quality of care with their allopathic MS care provider than did nonutilizers. We conclude that UT is complementary to allopathic medicine for people with MS.

Entities:  

Mesh:

Year:  1999        PMID: 10025800     DOI: 10.1212/wnl.52.3.626

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

3.  Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Authors:  Annett Apel; Brigitte Greim; Nicolaus König; Uwe K Zettl
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

Review 4.  Complementary and alternative medicine and coping in neuroimmunological diseases.

Authors:  A Apel; B Greim; U K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

5.  Complementary and alternative medicine use and nutrient intake among individuals with multiple sclerosis in the United States.

Authors:  Laura Masullo; Mia A Papas; Nancy Cotugna; Sandra Baker; Lauren Mahoney; Jillian Trabulsi
Journal:  J Community Health       Date:  2015-02

Review 6.  [Diet and multiple sclerosis].

Authors:  S Schwarz; H Leweling
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

7.  A randomized pilot study of naturopathic medicine in multiple sclerosis.

Authors:  Lynne Shinto; Carlo Calabrese; Cynthia Morris; Vijayshree Yadav; Debbie Griffith; Rachel Frank; Barry S Oken; Sara Baldauf-Wagner; Dennis Bourdette
Journal:  J Altern Complement Med       Date:  2008-06       Impact factor: 2.579

8.  Current Complementary and Alternative Therapies for Multiple Sclerosis.

Authors:  Allen C. Bowling; Thomas M. Stewart
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

9.  Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Vijayshree Yadav; Christopher Bever; James Bowen; Allen Bowling; Bianca Weinstock-Guttman; Michelle Cameron; Dennis Bourdette; Gary S Gronseth; Pushpa Narayanaswami
Journal:  Neurology       Date:  2014-03-25       Impact factor: 9.910

Review 10.  Complementary and alternative medicine in multiple sclerosis.

Authors:  Annett Apel-Neu; U K Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.